Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,311 | -13,447 | -11,572 | -3,489 | -1,561 |
| Depreciation Amortization | 187 | 721 | 536 | 351 | 175 |
| Accounts payable and accrued liabilities | -246 | 111 | 157 | 526 | 238 |
| Other Working Capital | -205 | 120 | 237 | 530 | 283 |
| Other Operating Activity | 340 | 5,830 | 5,685 | -479 | -569 |
| Operating Cash Flow | $-2,236 | $-6,666 | $-4,957 | $-2,560 | $-1,434 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -35 | -9 | -4 | -4 | -4 |
| Investing Cash Flow | $-35 | $-9 | $-4 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,255 | 1,100 | 1,100 | N/A |
| Common Stock Issued | 10,442 | 16,677 | 7,458 | N/A | N/A |
| Other Financing Activity | -88 | -105 | -46 | -383 | -242 |
| Financing Cash Flow | $10,354 | $17,828 | $8,512 | $717 | $-242 |
| Beginning Cash Position | 13,709 | 2,555 | 2,555 | 2,555 | 2,555 |
| End Cash Position | 21,792 | 13,709 | 6,106 | 708 | 875 |
| Net Cash Flow | $8,083 | $11,153 | $3,550 | $-1,848 | $-1,680 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,236 | -6,666 | -4,957 | -2,560 | -1,434 |
| Capital Expenditure | -35 | -9 | -4 | -4 | -4 |
| Free Cash Flow | -2,271 | -6,674 | -4,961 | -2,564 | -1,438 |